Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients : A Randomized, Multinational, Multicenter Trial

dc.contributorPontificia Universidad Javeriana. Facultad de Medicina. Departamento de Medicina Interna. Grupo de Investigación en Enfermedades Infecciosas HUSI - PUJ
dc.creatorCooper, David A.
dc.creatorCordery, Damien V.
dc.creatorZajdenverg, Roberto
dc.creatorRuxrungtham, Kiat
dc.creatorArastéh, Keikawus
dc.creatorBergmann, Frank
dc.creatorAndrade Neto, José L. de
dc.creatorScherer, Joseph
dc.creatorChaves, Ricardo L.
dc.creatorRobinson, Patrick
dc.date.accessioned2020-09-09T15:51:28Z
dc.date.accessioned2022-09-22T19:34:32Z
dc.date.available2020-09-09T15:51:28Z
dc.date.available2022-09-22T19:34:32Z
dc.date.created2020-09-09T15:51:28Z
dc.identifier1932-6203 (Electrónico)
dc.identifierhttp://hdl.handle.net/10554/51014
dc.identifierhttps://doi.org/10.1371/journal.pone.0144917
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3462352
dc.rightsAtribución-NoComercial 4.0 Internacional
dc.rightshttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourcePLoS ONE; Vol. 11 Núm. 1 (2016)
dc.titleTipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients : A Randomized, Multinational, Multicenter Trial
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución